Leslie Williams
Director/Board Member at WINDTREE THERAPEUTICS, INC.
Net worth: 232 195 $ as of 2024-03-30
Profile
Leslie J.
Williams is the founder of ImmusanT, Inc. (founded in 2010) and hC Bioscience, Inc. (founded in 2021).
At ImmusanT, Inc., Ms. Williams held the title of President, Chief Executive Officer & Director from 2010 to 2019.
At hC Bioscience, Inc., Ms. Williams currently holds the title of President, Chief Executive Officer & Director.
Ms. Williams's current job(s) include being the Lead Independent Director at Windtree Therapeutics, Inc. since 2021, Independent Director at Ocular Therapeutix, Inc. since 2019, Executive Director at UI College of Pharmacy since 2015, Operating Partner at Accelerator Services Corp since 2020, and a member of the Board of Advisors at Life Science Cares, Inc.Ms. Williams's former job(s) include being the President & Chief Executive Officer at Ventaira Pharmaceuticals, Inc. from 2003 to 2008, Director at Hepregen Corp.
from 2008 to 2014, Marketing Director at INO Therapeutics LLC, Director at CDI Bioscience, Inc. from 2006 to 2011, Director at The Capital Network, Inc. from 2009 to 2016, Principal at Merck & Co., Inc., Venture Partner at BVP Partners LLC, Principal at Inomax LLC (Florida), Account Manager at Datex-Ohmeda, Inc., and Principal at GlaxoSmithKline LLC.
Ms. Williams's education history includes an undergraduate degree from the University of Iowa and an MBA from Olin Business School, conferred in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OCULAR THERAPEUTIX INC
0.02% | 2023-06-13 | 25,433 ( 0.02% ) | 231 440 $ | 2024-03-30 |
| 2024-04-15 | 2,133 ( 0.03% ) | 755 $ | 2024-03-30 |
Leslie Williams active positions
| Companies | Position | Start |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Director/Board Member | 2019-03-19 |
| WINDTREE THERAPEUTICS, INC. | Director/Board Member | 2021-02-02 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 2020-09-30 |
Hc Bioscience, Inc.
 Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Founder | 2021-01-31 |
| UI College of Pharmacy | Director/Board Member | 2014-12-31 |
| Life Science Cares, Inc. | Director/Board Member | - |
Former positions of Leslie Williams
| Companies | Position | End |
|---|---|---|
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Founder | 2018-12-31 |
The Capital Network, Inc.
 The Capital Network, Inc. Miscellaneous Commercial ServicesCommercial Services The Capital Network, Inc. is a private company based in Wellesley, MA that provides founder-focused fundraising education programs. The company aims to create a more inclusive and accessible funding ecosystem to support female and other first-time founders of early stage startups. The company offers three programs: the Fellowship for Female Founders, Fundraising Readiness Workshops, and the Investment and Inclusion Series. The Fellowship for Female Founders is a six-month program that has helped over 90+ female founders raise over $85m in capital. The company also offers ongoing workshops for first-time startup founders and a series of honest conversations to bring about meaningful systemic change. The Capital Network has a network of 300+ investors and sponsors who help them make the fundraising ecosystem work for everybody. The company was founded by Ashkan Afkhami and Chula Reynolds. | Director/Board Member | 2015-12-31 |
Hepregen Corp.
 Hepregen Corp. Pharmaceuticals: MajorHealth Technology Hepregen Corp. develops bioengineering solutions for drug development. Its products include human HepatoPac and HepatoMune, rat, monkey, dog and multi species HepatoPac. The company was founded by Bernadette C. Fendrock, Sangeeta N. Bhatia and Salman Khetani in 2007 and is headquartered in Medford, MA. | Director/Board Member | 2013-12-31 |
| ░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Training of Leslie Williams
| University of Iowa | Undergraduate Degree |
| Olin Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Private companies | 13 |
|---|---|
Ventaira Pharmaceuticals, Inc.
 Ventaira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ventaira Pharmaceuticals Inc. develops aerosol devices. It offers inhaled drugs, including fentanyl for the treatment of breakthrough pain and salmeterol/flucticasone for asthma. The company was founded in April 2000 and is headquartered in Columbus, OH. | Health Technology |
Hepregen Corp.
Hepregen Corp. Pharmaceuticals: MajorHealth Technology Hepregen Corp. develops bioengineering solutions for drug development. Its products include human HepatoPac and HepatoMune, rat, monkey, dog and multi species HepatoPac. The company was founded by Bernadette C. Fendrock, Sangeeta N. Bhatia and Salman Khetani in 2007 and is headquartered in Medford, MA. | Health Technology |
BVP Partners LLC
 BVP Partners LLC Investment ManagersFinance BVP Partners LLC (BVP Partners) is a venture capital firm founded in the year 2003. The firm headquarters in Princeton. | Finance |
INO Therapeutics LLC
 INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Health Technology |
CDI Bioscience, Inc.
 CDI Bioscience, Inc. BiotechnologyHealth Technology CDI Bioscience, Inc. has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from explicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bio products. Recombinant therapeutic proteins have proven to be invaluable biopharmaceuticals for the treatment of chronic and life-threatening diseases. While exceptionally effective, the dosage requirements are generally very high for the required treatment. Several hundred milligrams of protein per administration is common and multiple doses are often required and being protein based drugs, they can only be produced by living cells which is why increasing production yield is a challenge. CDI Bioscience has developed a patented technology that dramatically improves the product yield in biopharmaceutical manufacturing. CDI's core technology, RP Shift®, solves a number of intermediate problems in the development of biopharmaceutical products by significantly boosting the productivity and viability of production cells. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Inomax LLC (Florida)
 Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Finance |
Datex-Ohmeda, Inc.
 Datex-Ohmeda, Inc. Industrial ConglomeratesProducer Manufacturing Part of General Electric Co., Datex-Ohmeda, Inc. develops and manufactures medical equipment. The private company is based in Madison, WI. | Producer Manufacturing |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
The Capital Network, Inc.
The Capital Network, Inc. Miscellaneous Commercial ServicesCommercial Services The Capital Network, Inc. is a private company based in Wellesley, MA that provides founder-focused fundraising education programs. The company aims to create a more inclusive and accessible funding ecosystem to support female and other first-time founders of early stage startups. The company offers three programs: the Fellowship for Female Founders, Fundraising Readiness Workshops, and the Investment and Inclusion Series. The Fellowship for Female Founders is a six-month program that has helped over 90+ female founders raise over $85m in capital. The company also offers ongoing workshops for first-time startup founders and a series of honest conversations to bring about meaningful systemic change. The Capital Network has a network of 300+ investors and sponsors who help them make the fundraising ecosystem work for everybody. The company was founded by Ashkan Afkhami and Chula Reynolds. | Commercial Services |
| Life Science Cares, Inc. | |
Hc Bioscience, Inc.
Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Leslie Williams
